Cancer

Recent news:

Clare Lou (left) and Derfogail Delcassian stand before a banner for the Innovative Genomics Institute

Delcassian receives seed funding for cancer research

October 1, 2024

Professor Derfogail Delcassian has been awarded $1 million in non-dilutive seed funding to accelerate the commercialization of her work on targeted molecular therapies for hard-to-treat cancers.

ImpriMed: Providing Personalized Medicine For Pets With Blood Cancer Diseases

June 17, 2024

Pulse 2.0 interviewed MTM alumnus Sungwon Lim, founder of ImpriMed, a company that provides personalized medicine for pets with blood cancer diseases.

Tony Consiglio, Alan Maida and Boris Rubinsky in their Etcheverry Hall lab. (Photo by Adam Lau/Berkeley Engineering)

Cool it down

June 11, 2024

How isochoric preservation can protect food, organs — and even the planet. Professor Boris Rubinsky discusses the state of the art in cryogenics and preservation.

photo of Messersmith

Messersmith receives 2023 Bakar Fellows Spark Award

August 31, 2023

Congratulations to Professor Phillip Messersmith, a recipient of the 2023 Bakar Fellows Spark Award for his work on gel protection during tumor ablation. The award is designed to accelerate faculty-led research and produce tangible, positive societal impact through commercialization.

Lung cancer screening logo

Undergraduate Alexandra Potter first author on lung cancer screening paper

March 30, 2022

Undergraduate bioengineering student Alexandra Potter has been a long-term collaborator with Dr. CJ Yang of Harvard University on the effectiveness of lung cancer screening. Today she is first author on a paper published in the British Medical Journal, “Association of computed tomography screening with lung cancer stage shift and survival in the United States.” Potter is also CEO of the American Lung Cancer Screening Initiative.